34 / 62
C o n t e n i d o d i s p o n i b l e e n h t t p : / / www. n e umo l o g i a - p e d i a t r i c a . cl
32
Neumol Pediatr 2016; 11 (1): 28 - 32
10. Chevaillier, J. Autogenic drainage: An airway clearance
technique. Unpublished abstracts 2000, 21st European
Cystic Fibrosis Conference (EWGCF), Davos, Switzerland.
11. Bradley JM, Moran FM, Elborn JS. Evidence for physical
therapies (airway clearance and physical training) in cystic
fibrosis: an overview of five Cochrane systematic reviews.
Respir Med 2006;100:191-201
12. Darbee JC, Ohtake PJ, Grant BJ, Cerny FJ. Physiological
evidence for the efficay of positive expiratory pressure
as an airway clearance technique in patients with cystic
fibrosis. Phys Ther 2004;84:524-37
13. Oberwaldner B, Evans JC, Zach MS. Forced expirations
against a variable resistance: a new chest physiotherapy
method in cystic fibrosis. Pediatr Pulmonol 1986;2:358-67
14. Oberwaldner B, Theissl B, Rucker A, Zach MS. Chest
physiotherapy in hospitalized patients with cystic fibrosis:
a study of lung function effects and sputum production. Eur
Respir J 1991; 4:152-58
15. Pfleger A, Theissl B, Oberwaldner B, Zach MS. Self-
administered chest physiotherapy in cystic fibrosis: a
comparative study of high-pressure PEP and autogenic
drainage. Lung 1992; 170:323-30
16. Zach MS, Oberwaldner B. Effect of positive expiratory
pressure breathing in patients with cystic fibrosis. Thorax
1992; 47:66-67
17. Brooks D, Newbold E, Kozar LF, Rivera M. The flutter device
and expiratory pressures. J Cardiopulm Rehabil 2002 ;
22:53-7
18. Eaton T, Young P, Zeng I, Kolbe J. A randomized evaluation
of the acute efficacy, acceptability and tolerability of flutter
and active cycle of breathing with and without postural
drainage in non cystic fibrosis bronchiectasis. Chron Respir
Dis 2007;4:23-30
19. Decramer M, Gosselink R. Physical activity in patients with
cystic fibrosis: a new variable in the health-status equation
unravelled? Eur Respir J 2006:678-9
20. Dennersten U, Lannefors L, Höglund P, Hellberg K, Johansson
H, Lagerkvist A-L, Ortfelt M, Sahlberg M, Eriksson L. Lung
function in the aging Swedish cystic fibrosis population.
Respir Med 2009;
21. Dolovich MB, Fink JB. Aerosols and devices. Respir Care
Clin N Am 2001; 7: 131-173
22. Dolovich MA. Influence of inspiratory flow rate, particle
size, and airway caliber on aerosolized drug delivery to the
lung. Respir Care 2000 ; 45: 597-608